B-Cell-targeted therapy for systemic lupus erythematosus

DRUGS

ADIS INT LTD

1. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR048303] Funding Source: NIH RePORTER
2. NIAMS NIH HHS [K08AR048303] Funding Source: Medline